SEC Form 4 · accession 0001209191-17-049934
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Harold Wilfred Cooper
Officer — President and CEO · Director
Period of report
Aug 21, 2017
Accepted (ET)
Aug 23, 2017 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $24.48 | Aug 21, 2017 | A | 60,000 | A | — | Aug 20, 2027 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1This option will vest and become exercisable in equal installments on the last day of 16 consecutive calendar quarters beginning with September 30, 2017 and ending on June 30, 2021.